Urology News

Prostate Cancer

Customized Ablation for Prostate Cancer Offers Favorable Early Results

Publish Date June 18, 2021

Investigators reported an 88% early treatment success rate in 52 men who underwent MRI-guided transurethral ultrasound ablation for localized prostate cancer.

Kidney Cancer

Delaying Surgical Intervention Not Likely to Increase Mortality in Patients With Metastatic Renal Cell Carcinoma

Publish Date June 18, 2021

Systematic review and meta-analysis assessed the impact of delayed surgical intervention on localized and metastatic renal cell carcinoma.

Prostate Cancer

Prostate Cancer Family History Warrants Earlier Risk-Based Screening

Publish Date June 17, 2021

A man’s optimal screening age depends on the number of first-degree male relatives affected by prostate cancer and their age at onset, investigators suggest.

Urology

SARS-CoV-2 Mortality Up for Patients With Active Cancer

Publish Date June 16, 2021

No link found for cancer-directed medical therapy with death; highest mortality rate seen for patients with hematologic malignancy

Prostate Cancer

Bone-Protecting Agents Reduce Fractures Associated With Treatment in Metastatic Castration-Resistant Prostate Cancer

Publish Date June 15, 2021

The cumulative incidence of bone fractures was below 5% in BPA recipients.

Prostate Cancer

Abiraterone Plus ADT and Docetaxel: A New SOC for Metastatic Castration-Sensitive Prostate Cancer?

Publish Date June 14, 2021

Abiraterone prolonged radiographic progression-free survival by 2.5 years.

Kidney Cancer

Understanding Adverse Effects Associated With Immune-Based Combination Therapies for Metastatic Renal Cell Carcinoma

Publish Date June 14, 2021

A meta-analysis of phase 3 randomized control trials sought to identify the TRAEs associated with 7 therapeutic regimens for the treatment of mRCC.

ERA-EDTA Congress

Chronic Kidney Disease Is More Common in the Cancer Population

Publish Date June 11, 2021

In a study conducted in Romania, the prevalence of CKD in patients with cancer was 11.9% compared with 8.8% in the general population.

ERA-EDTA Congress

Kidney Stone Risk Higher Among Men Than Women

Publish Date June 11, 2021

Modifiable risk factors accounted for only a fraction of the difference in stone rates between the sexes, according to investigators.

ERA-EDTA Congress

Cardiovascular Risk Differs for Stone Formers With ESKD

Publish Date June 10, 2021

Among patients with nephrolithiasis or urolithiasis, the cardiovascular event rate was 74.4 per 1000 person-years.